Nemecek R - Search Results

1

[Oncology in images: generalized Kaposi sarcoma].

Svoboda M, Grell P, Nemecek R, Sachlova M, Slampa P. Svoboda M, et al. Among authors: nemecek r. Klin Onkol. 2012;25(5):394. Klin Onkol. 2012. PMID: 23102203 Czech. No abstract available.

2

[Cetuximab and irinotecan for the treatment of metastatic colorectal cancer--pilot results from Masaryk Memorial Cancer Institute].

Nēmecek R, Kocáková I, Kocák I, Svoboda M, Lakomý R, Poprach A, Vyskocil J, Vyzula R. Nēmecek R, et al. Klin Onkol. 2009;22(1):27-33. Klin Onkol. 2009. PMID: 19534437 Czech.

3

[Bevacizumab in combination with capecitabine and irinotecan (XELIRI) in treatment of metastatic colorectal cancer].

Kocáková I, Kocák I, Svoboda M, Nemecek R, Rehák Z, Standara M. Kocáková I, et al. Among authors: nemecek r. Klin Onkol. 2009;22(2):73-6. Klin Onkol. 2009. PMID: 19522377 Czech.

4

[EGFR tyrosine kinase inhibitors as a targeted therapy for bronchioloalveolar carcinoma of the lung: a case report of a clinically prompt and intensive response and literature review].

Svoboda M, Fabian P, Slabý O, Stanková M, Lakomý R, Nemecek R, Vyzula R. Svoboda M, et al. Among authors: nemecek r. Klin Onkol. 2010;23(4):224-30. Klin Onkol. 2010. PMID: 20806820 Review. Czech.

5

[Current Possibilities for Predicting Responses to EGFR Blockade in Metastatic Colorectal Cancer].

Němeček R, Svoboda M, Slabý O. Němeček R, et al. Klin Onkol. 2016;29(3):187-95. doi: 10.14735/amko2016187. Klin Onkol. 2016. PMID: 27296403 Review. Czech.

6

MicroRNAs targeting EGFR signalling pathway in colorectal cancer.

Mlcochova J, Faltejskova P, Nemecek R, Svoboda M, Slaby O. Mlcochova J, et al. Among authors: nemecek r. J Cancer Res Clin Oncol. 2013 Oct;139(10):1615-24. doi: 10.1007/s00432-013-1470-9. Epub 2013 Jul 2. J Cancer Res Clin Oncol. 2013. PMID: 23817698 Review.

7

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.

Lupini L, Bassi C, Mlcochova J, Musa G, Russo M, Vychytilova-Faltejskova P, Svoboda M, Sabbioni S, Nemecek R, Slaby O, Negrini M. Lupini L, et al. Among authors: nemecek r. BMC Cancer. 2015 Oct 27;15:808. doi: 10.1186/s12885-015-1752-5. BMC Cancer. 2015. PMID: 26508446 Free PMC article.

8

[Cardiotoxicity of drugs used in oncology].

Poprach A, Petráková K, Vyskocil J, Lakomý R, Nemecek R, Kocák I, Kocáková I, Vyzula R. Poprach A, et al. Among authors: nemecek r. Klin Onkol. 2008;21(5):288-93. Klin Onkol. 2008. PMID: 19202960 Review. Czech.

9

[Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].

Lakomý R', Greplová K, Pilný R, Budinská E, Valík D, Poprach A, Nemecek R, Vyzula R. Lakomý R', et al. Among authors: nemecek r. Klin Onkol. 2009;22(5):228-32. Klin Onkol. 2009. PMID: 19886361 Czech.

10

MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.

Mlcochova J, Faltejskova-Vychytilova P, Ferracin M, Zagatti B, Radova L, Svoboda M, Nemecek R, John S, Kiss I, Vyzula R, Negrini M, Slaby O. Mlcochova J, et al. Among authors: nemecek r. Oncotarget. 2015 Nov 17;6(36):38695-704. doi: 10.18632/oncotarget.5735. Oncotarget. 2015. PMID: 26497852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters